片形吸虫排泄分泌产物的研究进展

doi:10.11843/j.issn.0366-6964.2017.02.002

Abstract

Abstract:

Fascioliasis is a sort of zoonotic disease caused by Fasciola spp., which can cause a large number of deaths in animals. It is considered to be a major problem for effecting on global public health and husbandry economic development. The method of resistance of host immune response that can survive in the host during the process of long-term mutual struggle between Fasciola spp. and its host. However, the excretory-secretory products (ESP) in different developmental stages of Fasciola spp. play a significant role in this process. In fact, ESP can be divided into oxidative stress related proteins, proteins related to energy metabolism and the proteasome associated proteins according to the functions. The ESP play important roles in the immune evasion of the Fasciola spp. Therefore, this dissertation expounded its functions with the purpose of providing implications for the research of new vaccines or drugs.

CLC Number:

S852.735

TIAN Ai-ling，ZHU Xing-quan，HUANG Si-yang. Research Advances in Excretory-secretory Products of Fasciola spp.[J]. ACTA VETERINARIA ET ZOOTECHNICA SINICA, 2017, 48(2): 201-206.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: https://www.xmsyxb.com/EN/10.11843/j.issn.0366-6964.2017.02.002

https://www.xmsyxb.com/EN/Y2017/V48/I2/201

References

［1］MAS-COMA S, BARGUES M D, VALERO M A. Fascioliasis and other plant-borne trematode zoonoses［J］. Int J Parasitol, 2005, 35(11-12): 1255-1278.
［2］MEEMON K, SOBHON P. Juvenile-specific cathepsin proteases in Fasciola spp.: their characteristics and vaccine efficacies［J］. Parasitol Res, 2015, 114(8): 2807-2813.
［3］PIEDRAFITA D, SPITHILL T W, SMITH R E, et al. Improving animal and human health through understanding liver fluke immunology［J］. Parasite Immunol, 2010, 32(8): 572-581.
［4］World Health Organization. Accelerating work to overcome the global impact of neglected tropical diseases: a roadmap for implementation-executive summary［R/OL］. Geneva, Switzerland: World Health Organization， 2012. ［2014-1-20］. http://www.who.int/neglected_diseases/NTD_RoadMap_2012_Fullversion.pdf.
［5］World Health Organization. The “neglected” neglected worms［J/OL］. Action against worms, 2007(10): 1. ［2016-12-12］.http://www.who.int/neglected_diseases/preventive_chemotheropy/Newsletters10.pdf.
［6］World Health Organization. Report of the WHO informal meeting on use of triclabendazole in fascioliasis control［R/OL］. WHO headquarters, Geneva, Switzerland, 17-18 October 2006. World Health Organization, Geneva. ISBN 92 4 154638 7. ［2016-12-12］http://www.who.int/neglected_diseases/preventive_chemotherapy/WHO_CDS_NTD_PCT_2007.1.pdf.
［7］ALASAAD S, SORIGUER R C, ABU-MADI M, et al. A TaqMan real-time PCR-based assay for the identification of Fasciola spp.［J］. Vet Parasitol, 2011, 179(1-3): 266-271.
［8］MAS-COMA S, VALERO M A, BARGUES M D. Fasciola, lymnaeids and human fascioliasis, with a global overview on disease transmission, epidemiology, evolutionary genetics, molecular epidemiology and control［J］. Adv Parasitol, 2009, 69: 41-146.
［9］MAS-COMA S, VALERO M A, BARGUES M D. Fascioliasis［J］. Adv Exp Med Biol, 2014, 766: 77-114.
［10］ROBINSON M W, DALTON J P, O'BRIEN B A, et al. Fasciola hepatica: the therapeutic potential of a worm secretome［J］. Int J Parasitol, 2013, 43(3-4): 283-291.
［11］JEFFERIES J R, CAMPBELL A M, VAN ROSSUM A J, et al. Proteomic analysis of Fasciola hepatica excretory-secretory products［J］. Proteomics, 2001, 1(9): 1128-1132.
［12］BOUKLI N M, DELGADO B, RICAURTE M, et al. Fasciola hepatica and Schistosoma mansoni: identification of common proteins by comparative proteomic analysis［J］. J Parasitol, 2011, 97(5): 852-861.
［13］GOURBAL B E, GUILLOU F, MITTA G, et al. Excretory-secretory products of larval Fasciola hepatica investigated using a two-dimensional proteomic approach ［J］. Mol Biochem Parasitol, 2008, 161(1): 63-66.
［14］BIENERT G P, SCHJOERRING J K, JAHN T P. Membrane transport of hydrogen peroxide［J］. Biochim Biophys Acta, 2006, 1758(8): 994-1003.
［15］ROBINSON M W, DALTON J P. Zoonotic helminth infections with particular emphasis on fasciolosis and other trematodiases［J］. Philos Trans R Soc Lond B Biol Sci, 2009, 364(1530): 2763-2776.
［16］CHANGKLUNGMOA N, KUEAKHAI P, APISAWETAKAN S, et al. Identification and expression of Fasciola gigantica thioredoxin［J］. Parasitol Res, 2014, 113(6): 2335-2343.
［17］HOLMGREN A, JOHANSSON C, BERNDT C, et al. Thiol redox control via thioredoxin and glutaredoxin systems［J］. Biochem Soc Trans, 2005, 33(Pt 6): 1375-1377.
［18］ALIRAHMI H, FARAHNAK A, GOLMOHAMADI T, et al. Comparative assay of glutathione S-transferase (GSTs) activity of excretory-secretory materials and somatic extract of Fasciola spp. parasites［J］. Acta Med Iran, 2010, 48(6): 367-370.
［19］PREYAVICHYAPUGDEE N, SAHAPHONG S, RIENGROIPITAK S, et al. Fasciola gigantica and Schistosoma mansoni: vaccine potential of recombinant glutathione S-transferase(rFgGST26) against infections in mice［J］. Exp Parasitol, 2008, 119(2): 229-237.
［20］MARTIN I, CABÁN-HERNÁNDEZ K, FIGUEROA-SANTIAGO O, et al. Fasciola hepatica fatty acid binding protein inhibits TLR4 activation and suppresses the inflammatory cytokines induced by lipopolysaccharide in vitro and in vivo［J］. J Immunol, 2015, 194(8): 3924-3936.
［21］MORPHEW R M, WRIGHT H A, LA-COURSE E J, et al. Comparative proteomics of excretory-secretory proteins released by the liver fluke Fasciola hepatica in sheep host bile and during in vitro culture ex host［J］. Mol Cell Proteomics, 2007, 6(6): 963-972.
［22］MAHANA N, ABD-ALLAH H A, SALAH M, et al. Fasciola gigantica enolase is a major component of worm tegumental fraction protective against sheep fasciolosis［J］. Acta Trop, 2016, 158: 189-196.
［23］DE GUZMAN J V, YU H S, JEONG H J, et al. Molecular characterization of two myoglobins of Paragonimus westermani［J］. J Parasitol, 2007, 93(1): 97-103.
［24］DEWILDE S, IOANITESCU A I, KIGER L, et al. The hemoglobins of the trematodes Fasciola hepatica and Paramphistomum epiclitum: a molecular biological, physico-chemical, kinetic, and vaccination study［J］. Protein Sci, 2008, 17(10): 1653-1662.
［25］ROBINSON M W, MENON R, DONNELLY S M, et al. An integrated transcriptomics and proteomics analysis of the secretome of the helminth pathogen Fasciola hepatica: proteins associated with invasion and infection of the mammalian host［J］. Mol Cell Proteomics, 2009, 8(8): 1891-1907.
［26］CHANTREE P, PHATSARA M, MEEMON K, et al. Vaccine potential of recombinant cathepsin B against Fasciola gigantica［J］. Exp Parasitol, 2013, 135(1): 102-109.
［27］CWIKLINSKI K, DALTON J P, DUFRESNE P J, et al. The Fasciola hepatica genome: gene duplication and polymorphism reveals adaptation to the host environment and the capacity for rapid evolution［J］. Genome Biol, 2015, 16: 71.
［28］SANSRI V, CHANGKLUNGMOA N, CHAICHANASAK P, et al. Molecular cloning, characterization and functional analysis of a novel juvenile-specific cathepsin L of Fasciola gigantica［J］. Acta Trop, 2013, 128(1): 76-84.
［29］CANCELA M, ACOSTA D, RINALDI G, et al. A distinctive repertoire of cathepsins is expressed by juvenile invasive Fasciola hepatica［J］. Biochimie, 2008, 90(10): 1461-1475.
［30］DONNELLY S, STACK C M, O’NEILL S M, et al. Helminth 2-Cys peroxiredoxin drives Th2 responses through a mechanism involving alternatively activated macrophages［J］. FASEB J, 2008, 22(11): 4022-4032.
［31］FLYNN R J, MANNION C, GOLDEN O, et al. Experimental Fasciola hepatica infection alters responses to tests used for diagnosis of bovine tuberculosis［J］. Infect Immun, 2007, 75(3): 1373-1381.
［32］罗洪林，张为宇，黄维义.大片吸虫组织蛋白酶L全长序列的获取及其生物信息学分析［J］.畜牧兽医学报，2008，39（2）：206-211.
LUO H L， ZHANG W Y, HUANG W Y. Isolation and bioinformatic analysis of Full-length catepsin L Gene［J］. Acta Veterinaria et Zootechnica Sinica， 2008，39（2）：206-211.（in Chinese）
［33］PÉREZ-SÁNCHEZ R, RAMAJO-HERNANDEZ A, RAMAJO-MARTIN V, et al. Proteomic analysis of the tegument and excretory-secretory products of adult Schistosoma bovis worms［J］. Proteomics, 2006, 6（Suppl 1）: S226-236.

[1]	ZHONG Haoran, HOU Ling, GUI Xiang, LÜ Rongxue, LIU Jinming, GU Shaopeng, JIN Yamei. The Correlation of HMGB1 with Liver Inflammatory Fibrosis Induced by Schistosoma japonicum [J]. Acta Veterinaria et Zootechnica Sinica, 2022, 53(10): 3609-3620.
[2]	ZHANG Yuan-yuan, XU Rong, HE Chuan-chuan, LI Xiao-chun, CHENG Gui-feng, GUO Lu, LIU Jin-ming, LI Hao, GU Shao-peng, JIN Ya-mei. Cloning,Expression and Functional Analysis of ELAV-like 2 Gene of Schistosoma japonicum [J]. ACTA VETERINARIA ET ZOOTECHNICA SINICA, 2018, 49(9): 1987-1997.
[3]	XING Feng，LIANG Zhi-peng，LI Cheng-lin. Study on Immune Response in Hetian Sheep and Chinese Merino Sheep Infection with Fasciola hepatica [J]. ACTA VETERINARIA ET ZOOTECHNICA SINICA, 2015, 46(3): 445-452.

Research Advances in Excretory-secretory Products of Fasciola spp.

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 3

Recommended Articles

Metrics

Comments